Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.tcm.2020.12.003 http://scihub22266oqcxt.onion/10.1016/j.tcm.2020.12.003 33338636!7831899!33338636     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33338636&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Trends+Cardiovasc+Med 2021 ; 31 (3): 135-140 Nephropedia Template TP {{tp|p=33338636|t=2021. Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021 |pdf=|usr=}}{{33338636}} gab.com Text Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021 JO: Trends Cardiovasc Med http://www.kidney.de/pget.php?&tw=1&pmid=33338636 #FOAvip As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing possibility that patients with COVID-19 may presen with ST-segment elevation myocardial infarction (STEMI). With social distancing and restricted access to preventive healthcare and emergency services, the management of acute cardiac emergencies such as myocardial infarction has suffered collateral damage. Thus far, global trends suggest a decrease in STEMI activations with possible worse outcomes due to delayed presentation and management. In this review, we discuss the challenges to STEMI management in the COVID-19 era and provide potential solutions for adherence to evidence-based therapies as the pandemic progresses into the year 2021. Twit Text FOAVip Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021 ????Trends Cardiovasc Med http://www.kidney.de/pget.php?&tw=1&pmid=33338636 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33338636 #FOAvip English Wikipedia <ref>{{Cite pmid|33338636}}</ref> Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021 #MMPMID33338636 Jain V; Gupta K; Bhatia K; Bansal A; Arora S; Khandelwal AK; Rosenberg JR; Levisay JP; Tommaso CL; Ricciardi MJ; Qamar A Trends Cardiovasc Med 2021[Apr]; 31 (3): 135-140 PMID33338636show ga As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing possibility that patients with COVID-19 may presen with ST-segment elevation myocardial infarction (STEMI). With social distancing and restricted access to preventive healthcare and emergency services, the management of acute cardiac emergencies such as myocardial infarction has suffered collateral damage. Thus far, global trends suggest a decrease in STEMI activations with possible worse outcomes due to delayed presentation and management. In this review, we discuss the challenges to STEMI management in the COVID-19 era and provide potential solutions for adherence to evidence-based therapies as the pandemic progresses into the year 2021. |COVID-19/*complications/epidemiology/prevention & control[MESH] |Humans[MESH] |Infection Control/*organization & administration[MESH] |Percutaneous Coronary Intervention[MESH]Management of STEMI during the COVID-19 pandemic: Lessons learned in 2(epmc).pdf DeepDyve Pubget Overpricing